CSIMarket Company Name, Ticker, Suppliers, else..
 
Biolife Solutions Inc   (BLFS)
Other Ticker:  
 
 
Price: $25.1200 $0.84 3.460%
Day's High: $25.43 Week Perf: 8.65 %
Day's Low: $ 24.52 30 Day Perf: -3.01 %
Volume (M): 345 52 Wk High: $ 26.73
Volume (M$): $ 8,671 52 Wk Avg: $17.86
Open: $24.52 52 Wk Low: $8.92



 Market Capitalization (Millions $) 1,156
 Shares Outstanding (Millions) 46
 Employees 103
 Revenues (TTM) (Millions $) 126
 Net Income (TTM) (Millions $) -73
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 2

Biolife Solutions Inc
Biolife Solutions Inc is a publicly traded biotechnology company that provides best-in-class cell and gene therapy products and services for cell-based research and clinical applications. The company is headquartered in Bothell, Washington, and was founded in 1998.

Biolife Solutions specializes in developing solutions to improve the biopreservation and storage of cells and tissues used in medical and research applications. Their products include biopreservation media, which optimize cellular viability and function during transportation, cold storage, and thawing. Biolife Solutions also provides GMP-manufactured clinical grade biopreservation media and contract manufacturing services to leading cell therapy and regenerative medicine companies.

The company's proprietary technologies include HypoThermosol and CryoStor, which are designed to preserve cells and tissues under controlled temperatures during transportation and storage. These technologies have been independently tested and validated and have been shown to increase cell viability and extend the lifespan of cells and tissues.

Biolife Solutions has a global presence and serves a diverse range of customers, from small biotech startups to large pharmaceutical companies. The company has partnerships with major research institutions, including the National Institutes of Health and leading universities.

Biolife Solutions has received several awards and recognitions for its innovative products and services. In 2016, BIOTECHNOLOGY MAGAZINE named the company as one of the "Top 10 Cell and Gene Therapy Technology Solution Providers". In 2019, the company was ranked as the 5th fastest-growing public company in the United States by Fortune Magazine.

In conclusion, Biolife Solutions Inc is a biotechnology company that focuses on developing biopreservation solutions to improve the storage and transportation of cells and tissues used in medical and research applications. Its proprietary technologies have been validated and demonstrated to optimize cellular viability and extend cell lifespan, making them a leading provider of cell and gene therapy products and services.


   Company Address: 3303 Monte Villa Parkway, Suite 310 Bothell 98021 WA
   Company Phone Number: 402-1400   Stock Exchange / Ticker: NASDAQ BLFS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Biolife Solutions Inc

Struggling Biolife Solutions Inc Faces Sharp Decline in Revenue and Ongoing Financial Challenges

Biolife Solutions Inc is facing a challenging period as indicated by their recent financial results. The company reported a loss per share of $-0.29 for the financial interval closing December 31, 2023, which is an improvement from the previous year but still signifies ongoing financial struggles.
The revenue for Biolife Solutions Inc has taken a significant hit, decreasing by -26.044% to $32.73 million from $44.26 million in the similar quarter a year before. This sharp decline in revenue is concerning and indicates potential issues within the company's operations or market demand. Additionally, the sequential decrease in revenue by -1.788% further highlights the company's difficulties in generating consistent income.
Furthermore, Biolife Solutions Inc reported a net loss of $-13.382 million for the same financial interval, a decrease from the deficit of $-50.228 million in the corresponding quarter a year ago. While the reduction in net loss is a positive development, it may not be enough to offset the overall financial challenges facing the company.
The increase in inventories to $43.5 million is also a cause for concern, as it suggests potential issues with inventory management or sluggish sales. The decrease in accounts receivable to $18.7 million may indicate slowing demand for Biolife Solutions Inc products, further impacting their financial performance.
Biolife Solutions Inc

Medical Equipment & Supplies Company, Biolife Solutions Inc, Reports Intensified Losses in Latest Financial Quarter

The stock market can be a volatile and unpredictable place, but it's important to stay informed and make educated decisions when it comes to investing. While companies may experience periods of growth and decline, it's crucial to evaluate the overall performance and potential of a company before making any investment decisions.
One company that has recently been in the spotlight is Biolife Solutions Inc, a player in the Medical Equipment & Supplies industry. In the financial span from July to September 30, 2023, Biolife Solutions experienced a loss per share of $-0.67, compared to $-0.23 the previous year. This loss per share grew from the preceding reporting season, indicating a challenging period for the company.
Biolife Solutions Inc

Biolife Solutions Inc Sees Dramatic Improvement in Q2 2023 Earnings Season, Vanishing Losses Spark Hope for Future Success



Biolife Solutions Inc, a company specializing in providing biopreservation tools and services for the healthcare industry, has recently reported discouraging results for the second quarter of the 2023 earnings season. With a decrease in earnings per share, declining revenue, and persistently rising losses, the company's financial performance raises concerns about the sustainability of its business model.
Earnings and Revenue Decline:
During the second quarter of 2023, Biolife Solutions Inc reported a loss per share of $-0.23, indicating a significant improvement compared to the loss per share of $-1.71 reported a year ago. While this reduction may appear positive at first glance, it remains worrying that the company continues to generate negative earnings.
Biolife Solutions Inc

Surpassing last year's shortfall and demonstrating solid growth, Biolife Solutions Inc's Topline sees a moderate increase in the latest fiscal period

Biolife Solutions Inc: A comprehensive insight into the medical equipment and supplies company.
Biolife Solutions Inc is a medical equipment and supplies company that has been providing products and solutions to the biomedical industry since its inception. The company was founded in 1990 and has since grown to become a significant player in the biomedical field, with a focus on cell and gene therapy products.






Biolife Solutions Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com